ArticleFrontiers in public health2026
Breaking silos, building bridges: leveraging Global Collaborative Evidence Networks for global health impact.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Global Collaborative Evidence Networks (GCENs), such as JBI, Cochrane, Campbell, the Guidelines International Network, and the Africa Evidence Network, bring together diverse actors to produce, synthesise, and disseminate evidence to inform policy and practise. Each is a distinct network in its own right, yet how these networks collaborate across networks remains underexplored, and persistent equity disparities in governance, agenda-setting, and capacity continue to constrain their collective impact. This study explores the challenges, facilitators, and benefits of collaboration across GCENs, drawing on participants recruited through the JBI Collaboration (JBIC), many of whom held active membership across multiple GCENs. Methods: A two-phase mixed-methods design was used. Phase 1 comprised an online survey of 213 JBI Collaboration Entity Directors, Convenors, and Deputies, analysed using descriptive statistics, cross-tabulation, and Pearson correlation coefficients. Phase 2 comprised a moderated director panel ( Results: Four themes emerged: navigating barriers, fostering synergy, amplifying impact through multiplex ties, and harmonising efforts. Collaboration is impeded by fragmented governance, resource constraints, and methodological duplication, yet is meaningfully enhanced by boundary-spanning brokers, face-to-face relationship-building, and shared strategic goals. Discussion: These exploratory findings offer a preliminary evidence base to inform a governance agenda for Global Collaborative Evidence Networks, in which formalised brokerage structures, strategic alignment, and equity-centred design may support the development of a more cohesive global evidence ecosystem.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.